PHASE-II TRIAL BIWEEKLY PACLITAXEL (P), DOXORUBICIN (D) AND GEMCITABINE (G) AS FIRST LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER (MBC) -PRELIMINARY-RESULTS

Citation
A. Lozano et al., PHASE-II TRIAL BIWEEKLY PACLITAXEL (P), DOXORUBICIN (D) AND GEMCITABINE (G) AS FIRST LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER (MBC) -PRELIMINARY-RESULTS, Annals of oncology, 9, 1998, pp. 84-84
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
84 - 84
Database
ISI
SICI code
0923-7534(1998)9:<84:PTBP(D>2.0.ZU;2-N